{"pmid":32320084,"title":"Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","text":["Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","We have read Char's comment(1) . Thanks for readers' attention and valuable feedback on our article. Following was our response to Char's question about data overlap. Firstly, the meta-analysis reprocessed the existing data about COVID-19 patients in published articles, and involved no other information outside of the article. This article is protected by copyright. All rights reserved.","J Med Virol","Long-Quan, Li","Tian, Huang","Yong-Qing, Wang","Zheng-Ping, Wang","Yuan, Liang","Tao-Bi, Huang","Hui-Yun, Zhang","Wei-Ming, Sun","Yu-Ping, Wang","32320084"],"abstract":["We have read Char's comment(1) . Thanks for readers' attention and valuable feedback on our article. Following was our response to Char's question about data overlap. Firstly, the meta-analysis reprocessed the existing data about COVID-19 patients in published articles, and involved no other information outside of the article. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Long-Quan, Li","Tian, Huang","Yong-Qing, Wang","Zheng-Ping, Wang","Yuan, Liang","Tao-Bi, Huang","Hui-Yun, Zhang","Wei-Ming, Sun","Yu-Ping, Wang"],"date":"2020-04-23T11:00:00Z","year":2020,"_id":"32320084","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25924","source":"PubMed","weight":0,"_version_":1664815087829909506,"score":8.518259,"similar":[{"pmid":32314808,"title":"Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","text":["Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","I have read with great interest the article \"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis\" by Li and colleagues(1) . The authors have conducted a comprehensive search for articles concerning the clinical characteristics of Chinese patients with COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Leung, Char","32314808"],"abstract":["I have read with great interest the article \"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis\" by Li and colleagues(1) . The authors have conducted a comprehensive search for articles concerning the clinical characteristics of Chinese patients with COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Leung, Char"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314808","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25912","source":"PubMed","weight":0,"locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664714520123146240,"score":392.13834},{"pmid":32162702,"title":"COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","text":["COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.","The aim of this study was to analyze the clinical data, discharge rate, and fatality rate of COVID-19 patients for clinical help. The clinical data of COVID-19 patients from December 2019 to February 2020 were retrieved from four databases. We statistically analyzed the clinical symptoms and laboratory results of COVID-19 patients and explained the discharge rate and fatality rate with a single-arm meta-analysis. The available data of 1994 patients in 10 literatures were included in our study. The main clinical symptoms of COVID-19 patients were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Minor symptoms include headache or dizziness (12.1%), diarrhea (4.8%), nausea and vomiting (3.9%). The results of the laboratory showed that the lymphocytopenia (64.5%), increase of C-reactive protein (44.3%), increase of lactic dehydrogenase (28.3%), and leukocytopenia (29.4%) were more common. The results of single-arm meta-analysis showed that the male took a larger percentage in the gender distribution of COVID-19 patients 60% (95% CI [0.54, 0.65]), the discharge rate of COVID-19 patients was 52% (95% CI [0.34,0.70]), and the fatality rate was 5% (95% CI [0.01,0.11]).","J Med Virol","Li, Long-Quan","Huang, Tian","Wang, Yong-Qing","Wang, Zheng-Ping","Liang, Yuan","Huang, Tao-Bi","Zhang, Hui-Yun","Sun, Weiming","Wang, Yuping","32162702"],"abstract":["The aim of this study was to analyze the clinical data, discharge rate, and fatality rate of COVID-19 patients for clinical help. The clinical data of COVID-19 patients from December 2019 to February 2020 were retrieved from four databases. We statistically analyzed the clinical symptoms and laboratory results of COVID-19 patients and explained the discharge rate and fatality rate with a single-arm meta-analysis. The available data of 1994 patients in 10 literatures were included in our study. The main clinical symptoms of COVID-19 patients were fever (88.5%), cough (68.6%), myalgia or fatigue (35.8%), expectoration (28.2%), and dyspnea (21.9%). Minor symptoms include headache or dizziness (12.1%), diarrhea (4.8%), nausea and vomiting (3.9%). The results of the laboratory showed that the lymphocytopenia (64.5%), increase of C-reactive protein (44.3%), increase of lactic dehydrogenase (28.3%), and leukocytopenia (29.4%) were more common. The results of single-arm meta-analysis showed that the male took a larger percentage in the gender distribution of COVID-19 patients 60% (95% CI [0.54, 0.65]), the discharge rate of COVID-19 patients was 52% (95% CI [0.34,0.70]), and the fatality rate was 5% (95% CI [0.01,0.11])."],"journal":"J Med Virol","authors":["Li, Long-Quan","Huang, Tian","Wang, Yong-Qing","Wang, Zheng-Ping","Liang, Yuan","Huang, Tao-Bi","Zhang, Hui-Yun","Sun, Weiming","Wang, Yuping"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32162702","week":"202011|Mar 09 - Mar 15","doi":"10.1002/jmv.25757","keywords":["2019-ncov","covid-19","clinical characteristics","discharge rate","fatality rate","meta-analysis"],"source":"PubMed","topics":["Mechanism"],"weight":1,"locations":["myalgia","fatigue"],"_version_":1664640874777149440,"score":216.85136},{"pmid":32232977,"title":"Response to \"Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '\".","text":["Response to \"Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '\".","We thank Dr. Yang and colleagues for their attention to our article(1,2) . And we appreciate their meaningful suggestions, which we highly agree with. With the purpose of letting the public know the overall situation of the clinical trials of new coronary pneumonia in China as soon as possible, we completed the data collection and brief analysis in a very short time. This article is protected by copyright. All rights reserved.","J Med Virol","Zhang, Qi","Wang, Yakun","Qi, Changsong","Shen, Lin","Li, Jian","32232977"],"abstract":["We thank Dr. Yang and colleagues for their attention to our article(1,2) . And we appreciate their meaningful suggestions, which we highly agree with. With the purpose of letting the public know the overall situation of the clinical trials of new coronary pneumonia in China as soon as possible, we completed the data collection and brief analysis in a very short time. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zhang, Qi","Wang, Yakun","Qi, Changsong","Shen, Lin","Li, Jian"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32232977","week":"202014|Mar 30 - Apr 05","doi":"10.1002/jmv.25803","source":"PubMed","weight":0,"locations":["China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664638455326441473,"score":192.27925},{"pmid":32297983,"title":"Case fatality rate analysis of Italian COVID-19 outbreak.","text":["Case fatality rate analysis of Italian COVID-19 outbreak.","The Italian outbreak of COVID-19 cases is a public health emergency and there is a worldwide tremendous interest in the evaluation of the Italian epidemic evolution. Indeed, from February 2020, Italy is facing an explosion of COVID-19 cases. In particular, the Italian observed case fatality rate (CFR) is much higher than the other countries. Recently, it has been hypothesized that the extensive number of intergenerational contacts - typical of Italian culture - could contribute to explain the high number of deaths observed in Italy. However, through an analysis performed for all the Italian regions, here it is shown that the deaths are localized in specific regions and that the CFRs of different Italian regions are overlapping with the rates of European countries. Moreover, through a correlation analyses between CFRs and different social habits, it is shown that no positive correlation is observed between social behaviours and CFRs. In conclusion, this analyses clearly rejects the possibility that social habits and intergenerational contacts can contribute to explain such a profound effect on the number of deaths observed in Italy during COVID-19 outbreak and more effort should be addressed to evaluate the real amount of positive cases. This article is protected by copyright. All rights reserved.","J Med Virol","Giangreco, Giovanni","32297983"],"abstract":["The Italian outbreak of COVID-19 cases is a public health emergency and there is a worldwide tremendous interest in the evaluation of the Italian epidemic evolution. Indeed, from February 2020, Italy is facing an explosion of COVID-19 cases. In particular, the Italian observed case fatality rate (CFR) is much higher than the other countries. Recently, it has been hypothesized that the extensive number of intergenerational contacts - typical of Italian culture - could contribute to explain the high number of deaths observed in Italy. However, through an analysis performed for all the Italian regions, here it is shown that the deaths are localized in specific regions and that the CFRs of different Italian regions are overlapping with the rates of European countries. Moreover, through a correlation analyses between CFRs and different social habits, it is shown that no positive correlation is observed between social behaviours and CFRs. In conclusion, this analyses clearly rejects the possibility that social habits and intergenerational contacts can contribute to explain such a profound effect on the number of deaths observed in Italy during COVID-19 outbreak and more effort should be addressed to evaluate the real amount of positive cases. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Giangreco, Giovanni"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297983","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25894","keywords":["covid-19","case fatality rate","italy","outbreak","sars-cov-2","social behaviour"],"source":"PubMed","weight":0,"locations":["Italian","Italian","Italy","Italian","Italian","Italy","Italian","Italian","Italy","Italian"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"_version_":1664641388364431360,"score":190.30992},{"pmid":32330302,"title":"Comment on \"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19\".","text":["Comment on \"Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19\".","I read with this informative review article by Cheng et al. \" Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19\". I would like to talk about the role of ACE2 in endothelial cell function. Besides, I would like to mention that COVID-19 patients might benefit from ACEI/ARBs concerning improving endothelial dysfunction in COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Hu, Shuaishuai","32330302"],"abstract":["I read with this informative review article by Cheng et al. \" Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19\". I would like to talk about the role of ACE2 in endothelial cell function. Besides, I would like to mention that COVID-19 patients might benefit from ACEI/ARBs concerning improving endothelial dysfunction in COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Hu, Shuaishuai"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330302","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25937","keywords":["ace2","acei/arbs","covid-19","endothelial dysfunction"],"source":"PubMed","topics":["Treatment","Mechanism"],"weight":1,"_version_":1664996914849906688,"score":172.21713}]}